Susan Groshen

6PUBLICATIONS
38CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Aug 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.

Sarmad Sadeghi, David Quinn, Tanya Dorff

|Jul 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Steven G DuBois, M Meaghan Granger, Susan Groshen

|Jun 26, 2019
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method.

Lingyun Ji, Juan Pablo Lewinger, Mark Krailo

|Aug 11, 2018
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

Steven G DuBois, Yael P Mosse, Elizabeth Fox

Pageof 1

Frequent Collaborators

3 joint publications

Brian Weiss

2 joint publications

Steven G DuBois

2 joint publications

John M Maris

2 joint publications

Julie R Park